Tag: Kano Therapeutics

Kano Therapeutics has filed a notice of an exempt offering of securities to raise $5,050,000.00 in New Equity Investment.

Kano Therapeutics has filed a notice of an exempt offering of securities to raise $5,050,000.00 in New Equity Investment.

According to filings with the U.S. Securities and Exchange Commission, Kano Therapeutics is raising up to $5,050,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Floris Engelhardt played a…

Read More Read More